Sort by
Refine Your Search
-
Country
-
Employer
- Indiana University
- Fred Hutchinson Cancer Center
- Leiden University
- Northeastern University
- University of North Carolina at Chapel Hill
- Durham University
- FAPESP - São Paulo Research Foundation
- Institute of Geological Sciences, Polish Academy of Sciences
- Instituto Politécnico de Bragança
- Josep Carreras Leukaemia Research Institute (IJC)
- Nantes Université
- National Institute of Research and Innovation
- National Institute of Research and Innovation
- St Jude Children's Research Hospital
- The University of Arizona
- University of Arkansas
- University of Aveiro
- University of Minnesota
- 8 more »
- « less
-
Field
-
/2004, of August 18, in its current wording; FCT, I.P. Research Grant Regulations, in force (https://www.fct.pt/wp-content/uploads/2026/01/RBi_Republicado_2025.pdf ); Regulation No. 522/2020, published in
-
of the patient specific personalized solutions for bone regeneration and it includes material development, pre-clinical evaluation, and clinical trials. The successful candidate will join NIRI and will be a part
-
. For more information see: https://medicine.iu.edu/faculty-labs/witczak Successful candidates will have recently completed PhD training, possess a strong background in type 2 diabetes, metabolism, and/or
-
. For more information see: https://medicine.iu.edu/faculty-labs/witczak Successful candidates will have recently completed PhD training, possess a strong background in type 2 diabetes, metabolism, and/or
-
to staff position within a Research Infrastructure? No Offer Description Activities and context: The fellow will be responsible for 1) assisting in the generation of data for the “Making Bones Talk
-
-science researchers. Depending on the successful candidate's expertise the work will focus either on biomaterials for the repair and regeneration of bone defects or on biomaterials and nanoparticles
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 10 days ago
the School’s Strategic Plan (https://pharmacy.unc.edu/about/oe/strategic-plan/). Our Vision is to be the global leader in pharmacy and pharmaceutical sciences. Our Mission is to prepare leaders and innovators
-
fate in the bone marrow and influences disease outcomes, ranging from immune tolerance and clonal expansion to graft-versus-leukemia activity and bone marrow failure. Using state-of-the-art mouse models
-
actors’ is recognised internationally as a core element of Open Science (OS). However, current frameworks for monitoring OS are ill-equipped for capturing the variety and impact of such Public Engagement
-
-society dialogue and building public trust in the knowledge production process, ‘open engagement with societal actors’ is recognised internationally as a core element of Open Science (OS). However, current